Skip to content
Life Sciences Series B Founded 2009

DermaSensor

Developer of an AI-powered skin cancer detection device

📍 Miami, United States · Dermatology

Funding snapshot

Last roundSeries B
Amount$5M
Date10 June 2026

About

Developer of an AI-powered skin cancer detection device. The company offers DermaSensor device that uses a combination of cutting-edge optical spectroscopy and artificial intelligence to promptly analyze suspicious skin lesions. The device shines light bursts on a lesion, captures scattered light spectra, and uses proprietary AI algorithms to assess malignancy risk for melanoma, basal cell carcinoma, and squamous cell carcinoma.

Latest news

No articles yet.

Raising like DermaSensor?

Analyze your pitch deck before your next raise.

Analyze My Deck →